Literature DB >> 1664831

Comparative pharmacokinetic disposition of fluoroquinolones in the lung.

R Wise1, D R Baldwin, J M Andrews, D Honeybourne.   

Abstract

The problems associated with the study of the penetration of quinolones into the respiratory tract are discussed. New techniques allow the study of the penetration of these agents into bronchial mucosa, alveolar macrophages and epithelial lining fluid. In general quinolones are concentrated in bronchial mucosa approximately 1.5 times compared with serum. In alveolar macrophages, the agents are concentrated 14- to 18-fold compared with serum and the ratio of alveolar macrophage levels to those in epithelial lining fluid are 7.7 to 5.7:1. The concentrations of temafloxacin and ciprofloxacin in these sites suggests that these agents will be efficacious in the therapy of respiratory infections caused by Streptococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664831     DOI: 10.1093/jac/28.suppl_c.65

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Penetration of orally administered prulifloxacin into human lung tissue.

Authors:  Ercole Concia; Benedetta Allegranzi; Giovanni B Ciottoli; Giovanna Orticelli; Marcello Marchetti; Paolo Dionisio
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

Authors:  Keith A Rodvold; Jomy M George; Liz Yoo
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

3.  New and future antibiotics in the treatment of acute respiratory tract infections.

Authors:  R Wise
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

4.  Effects of enrofloxacin on porcine phagocytic function.

Authors:  E J Schoevers; L A van Leengoed; J H Verheijden; T A Niewold
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

Review 5.  Lomefloxacin clinical pharmacokinetics.

Authors:  C D Freeman; D P Nicolau; P P Belliveau; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.